Effect of the Support, Educate, Empower Personalized Glaucoma Coaching Program on Medication Adherence: The SEE Program Randomized Clinical Trial.

ABSTRACT:

Importance

Medication nonadherence contributes to vision loss from glaucoma, a leading cause of irreversible blindness in the US. Intervention to improve adherence can benefit health outcomes and quality of life, while reducing health system and public health burden.

Objective

To compare the Support, Educate, Empower (SEE) intervention with standard written education on glaucoma medication adherence.

Design, setting, and participants

The SEE study was a parallel, nonmasked, 1:1 randomized clinical trial testing intervention superiority. Participants were recruited from the University of Michigan (UM) and Henry Ford Health System (HFHS) between April 27, 2021, and December 18, 2023. Adults with glaucoma taking 1 or more ocular hypotensive eye drop medications who self-

SUBMITTER: Newman-Casey PA 

PROVIDER: S-EPMC12947086 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature